Published in Hepat Mon on December 14, 2013
Hyaluronan as a therapeutic target in human diseases. Adv Drug Deliv Rev (2015) 0.81
How to start interventional radiology. Iran Red Crescent Med J (2013) 0.79
Hyaluronic acid concentration in liver diseases. Clin Exp Med (2015) 0.77
Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C. Medicine (Baltimore) (2016) 0.77
Intrahepatic Fat Content and Markers of Hepatic Fibrosis in Obese Children. Int J Endocrinol (2016) 0.75
Effects of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D Concentrations in Cirrhotic Patients: A Randomized Controlled Trial. Nutrients (2016) 0.75
Hyaluronan: its nature, distribution, functions and turnover. J Intern Med (1997) 4.55
Hyaluronan as an immune regulator in human diseases. Physiol Rev (2011) 2.74
Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev (2006) 2.47
Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta (2007) 2.10
Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol (2000) 2.06
Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C. Liver Transpl (2008) 1.49
Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D. Turk J Gastroenterol (2011) 1.48
Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. Hepatology (2009) 1.47
Post-prandial serum hyaluronan concentration in patients with chronic liver disease. Intern Med (1998) 1.46
Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem (1996) 1.38
Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. World J Gastroenterol (2005) 1.30
Hyaluronan promotes the malignant phenotype. Glycobiology (2002) 1.28
Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. Liver Int (2005) 1.27
Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol (2005) 1.27
Experimental approaches to hyaluronan structure. Carbohydr Res (2005) 1.27
Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol (2005) 1.25
Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. BMC Gastroenterol (2005) 1.21
Liver fibrosis and inflammation. A review. Ann Hepatol (2004) 1.11
Tissue uptake of circulating hyaluronic acid. A whole body autoradiographic study. Cell Tissue Res (1983) 1.10
Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. J Gastroenterol Hepatol (2003) 1.09
Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology (1996) 1.03
The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection. PLoS One (2011) 1.02
Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease. Transl Res (2010) 1.02
Assessing liver fibrosis with serum marker models. Clin Biochem Rev (2007) 1.02
Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B. World J Gastroenterol (2008) 0.99
Serum hyaluronate as a marker of hepatic derangement in acute liver damage. J Hepatol (1991) 0.97
Serum hyaluronic acid as a comprehensive marker to assess severity of liver disease in schistosomiasis. Acta Trop (2002) 0.96
Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease. Acta Biochim Pol (2011) 0.93
Update of liver fibrosis and steatosis with transient elastography (Fibroscan). Gastroenterol Rep (Oxf) (2013) 0.90
Serum hyaluronan and hyaluronidase: very early markers of toxic liver injury. Clin Chim Acta (2004) 0.90
Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients? BMC Infect Dis (2010) 0.90
Serum hyaluronic acid as a noninvasive marker of hepatic fibrosis in chronic hepatitis B. Saudi J Gastroenterol (2008) 0.90
Assessment of liver fibrosis development in chronic hepatitis B patients by serum hyaluronic acid and laminin levels. Acta Clin Croat (2010) 0.89
Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis. Int J Clin Pract (2007) 0.88
Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infection. Clin Chim Acta (2006) 0.88
Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease. J Pediatr Gastroenterol Nutr (2006) 0.87
The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients. Hum Exp Toxicol (2012) 0.86
Measurement of serum hyaluronic acid level during the perioperative period of liver resection for evaluation of functional liver reserve. J Gastroenterol Hepatol (2001) 0.86
Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients. PLoS One (2013) 0.85
Effects of eating on plasma hyaluronan in patients with cirrhosis: its mechanism and influence on clinical interpretation. J Gastroenterol Hepatol (1998) 0.84
Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy? Ann Clin Biochem (2005) 0.84
Hyaluronic acid in the evaluation of liver fibrosis in patients with hepatitis C on haemodialysis. Braz J Infect Dis (2010) 0.82
Serum hyaluronic acid level does not reliably differentiate minimal and significant liver disease in chronic hepatitis C. Saudi Med J (2011) 0.81
Evaluation of serum hyaluronic acid level and hyaluronidase activity in acute and chronic hepatitis C. J Int Med Res (2007) 0.80
Would the physicians eventually obsolete the liver biopsy for the assessment of liver fibrosis? Hepat Mon (2012) 0.79
Serum hyaluronic acid and laminin as potential tumor markers for upper gastrointestinal cancers. Eur J Intern Med (2011) 0.78
Serum hyaluronan: a marker of liver fibrosis in patients with chronic liver disease. Asian Pac J Allergy Immunol (2003) 0.78
Relationship between serum concetrations of type III procollagen, hyluronic acid and histopathological findings in the liver of HCV-positive blood donors. Arq Gastroenterol (2007) 0.77